Study of IBI318 in Patients With Advanced Cutaneous Squamous Cell Carcinoma

NCT04611321 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
15
Enrollment
INDUSTRY
Sponsor class

Stopped Due to the company's development strategy adjustment, Innovent Biologics has decided not to continue this study after consultation with investigators.

Conditions

Interventions

Sponsor

Innovent Biologics (Suzhou) Co. Ltd.